famotidine has been researched along with Hematoma, Subdural in 1 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
Hematoma, Subdural: Accumulation of blood in the SUBDURAL SPACE between the DURA MATER and the arachnoidal layer of the MENINGES. This condition primarily occurs over the surface of a CEREBRAL HEMISPHERE, but may develop in the spinal canal (HEMATOMA, SUBDURAL, SPINAL). Subdural hematoma can be classified as the acute or the chronic form, with immediate or delayed symptom onset, respectively. Symptoms may include loss of consciousness, severe HEADACHE, and deteriorating mental status.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yoshimoto, K | 1 |
| Saima, S | 1 |
| Echizen, H | 1 |
| Nakamura, Y | 1 |
| Kondo, T | 1 |
| Yagishita, Y | 1 |
| Ishizaki, T | 1 |
1 review available for famotidine and Hematoma, Subdural
| Article | Year |
|---|---|
Famotidine-associated central nervous system reactions and plasma and cerebrospinal drug concentrations in neurosurgical patients with renal failure.
Topics: Aged; Aged, 80 and over; Central Nervous System Diseases; Famotidine; Female; Hematoma, Subdural; Hu | 1994 |